US Stock MarketDetailed Quotes
ATBPF ANTIBE THERAPEUTICS INC
- 0.215600
- 0.0000000.00%
15min DelayClose Apr 8 16:00 ET
11.43MMarket Cap-845P/E (TTM)
0.000000High0.000000Low0Volume0.215600Open0.215600Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)53.01MShares0.88550052wk High0.60P/B11.43MFloat Cap0.11130052wk Low--Dividend TTM53.01MShs Float5.000000Historical High--Div YieldTTM0.00%Amplitude0.111300Historical Low--Avg Price1Lot Size
ANTIBE THERAPEUTICS INC Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.66%-3.85M | -6.43M | -4.58M | 3.63%-16.31M | -3.38M | -3.61M | -16,014.29%-16.92M | 99.12%-105K | -69.15%-11.94M | -9.38%-7.06M |
| Net income from continuing operations | 2.41%-4.21M | ---5.01M | ---5.79M | 22.29%-19.48M | ---3.55M | ---4.32M | -1.32%-25.06M | -27.88%-24.73M | -50.92%-19.34M | -72.49%-12.82M |
| Operating gains losses | ---- | ---- | ---- | --348K | --250K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | -79.29%99K | -16.43%478K | 37.43%572K | 10.36%416.22K |
| Other non cash items | ---- | ---- | ---- | -177.78%-14K | --0 | ---18K | -65.38%18K | -69.05%52K | 27.78%168K | -81.08%131.47K |
| Change In working capital | 58.52%-73K | ---1.35M | --786K | -98.88%28K | ---537K | ---176K | -87.27%2.5M | 1,062.57%19.66M | -24.05%1.69M | 567.79%2.23M |
| -Change in receivables | 117.48%57K | ---142K | --67K | 54.36%443K | ---109K | ---326K | 111.94%287K | -6,575.00%-2.4M | 91.46%-36K | -824.09%-421.63K |
| -Change in inventory | --0 | --0 | --0 | -141.41%-239K | --0 | --59K | -118.68%-99K | 185.35%530K | -304.85%-621K | 185.80%303.15K |
| -Change in prepaid assets | -131.72%-59K | --342K | ---927K | -114.44%-219K | ---419K | --186K | 169.40%1.52M | -31,128.57%-2.19M | -146.54%-7K | -45.16%15.04K |
| -Change in payables and accrued expense | 25.26%-71K | ---1.55M | --1.65M | -127.23%-217K | ---9K | ---95K | 152.68%797K | -164.25%-1.51M | 132.72%2.36M | 1,112.76%1.01M |
| -Change in other working capital | ---- | ---- | ---- | --260K | --0 | --0 | ---- | --25.23M | ---- | 29,309.46%1.32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.66%-3.85M | ---6.43M | ---4.58M | 3.63%-16.31M | ---3.38M | ---3.61M | -16,014.29%-16.92M | 99.12%-105K | -69.15%-11.94M | -9.38%-7.06M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1,975.38%11.04M | 1.78M | 6.62M | 41.51%-11.83M | -549K | 532K | -7,559.09%-20.22M | -369.39%-264K | 138.07%98K | -408.33%-257.4K |
| Net PPE purchase and sale | ---- | ---- | ---- | 0.00%-9K | --2K | ---- | ---9K | ---- | --0 | -210.85%-157.4K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | 235.17%319K | ---240K | ---- | ---236K | ---- | ---- | ---- |
| Net investment purchase and sale | 63,637.50%10.17M | --1.78M | --6.62M | 39.24%-12.14M | ---311K | ---16K | ---19.98M | ---- | 200.00%100K | ---100K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---264K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 1,975.38%11.04M | --1.78M | --6.62M | 41.51%-11.83M | ---549K | --532K | -7,559.09%-20.22M | -369.39%-264K | 138.07%98K | -408.33%-257.4K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 407.69%80K | 159K | -1K | -100.04%-26K | 451.20%66.16M | 25.20%12M | 9.55%9.59M |
| Net issuance payments of debt | --0 | --0 | --0 | 48.03%-79K | --0 | ---1K | 93.69%-152K | -1,181.91%-2.41M | -127.88%-188K | 385.15%674.33K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 758.57%69.12M | 35.77%8.05M | 18.99%5.93M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | -97.47%128K | -0.12%5.07M | 32.54%5.08M | -2.16%3.83M |
| Net other financing activities | ---- | ---- | ---- | 8,050.00%159K | ---- | ---- | 99.96%-2K | -501.07%-5.61M | -10.48%-934K | -198.30%-845.43K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 407.69%80K | --159K | ---1K | -100.04%-26K | 451.20%66.16M | 25.20%12M | 9.55%9.59M |
| Net cash flow | ||||||||||
| Beginning cash position | -69.54%4.14M | --8.79M | --6.76M | -51.64%34.81M | --10.53M | --13.6M | 1,064.23%71.97M | 3.15%6.18M | 60.85%5.99M | 148.06%3.73M |
| Current changes in cash | 334.09%7.2M | ---4.65M | --2.04M | 24.52%-28.05M | ---3.77M | ---3.07M | -156.49%-37.17M | 39,533.13%65.79M | -92.70%166K | 1.05%2.27M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 425.32%23K | 73.51%-7.07K |
| End cash Position | 7.69%11.34M | --4.14M | --8.79M | -80.59%6.76M | --6.76M | --10.53M | -51.64%34.81M | 1,064.23%71.97M | 3.16%6.18M | 60.85%5.99M |
| Free cash flow | -6.33%-3.85M | ---6.43M | ---4.58M | 3.63%-16.31M | ---3.38M | ---3.62M | -16,022.86%-16.93M | 99.12%-105K | -65.49%-11.94M | -10.95%-7.21M |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg